Optipharm.CO.LTD (153710) — Financial Flexibility Index
Optipharm.CO.LTD (153710) has a Financial Flexibility Index of -0.01x as of December 2025. Free cash flow of ₩-97.44 Million (operating CF ₩-408.70 Million minus capex ₩311.27 Million) represents 0% of total liabilities (₩15.37 Billion). Check strategic asset allocation of Optipharm.CO.LTD to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Optipharm.CO.LTD Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Optipharm.CO.LTD across 11 annual periods. See how liquid is Optipharm.CO.LTD's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Optipharm.CO.LTD (2015–2025)
Year-by-year free cash flow to debt coverage for Optipharm.CO.LTD. For the full company profile including market capitalisation, see 153710 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | ₩990.05 Million | ₩-1.55 Billion | ₩15.37 Billion | ▼ -9.7% |
| 2024 | 0.07x | ₩1.14 Billion | ₩-595.50 Million | ₩15.98 Billion | ▲ +6829.7% |
| 2023 | 0.00x | ₩14.55 Million | ₩-1.72 Billion | ₩14.13 Billion | ▼ -99.4% |
| 2022 | 0.18x | ₩2.17 Billion | ₩-2.43 Billion | ₩12.17 Billion | ▲ +250.2% |
| 2021 | -0.12x | ₩-1.21 Billion | ₩-1.97 Billion | ₩10.21 Billion | ▼ -23.3% |
| 2020 | -0.10x | ₩-725.76 Million | ₩-1.62 Billion | ₩7.54 Billion | ▼ -154.8% |
| 2019 | 0.18x | ₩1.07 Billion | ₩447.47 Million | ₩6.11 Billion | ▼ -10.1% |
| 2018 | 0.20x | ₩1.41 Billion | ₩1.20 Billion | ₩7.20 Billion | ▲ +48.1% |
| 2017 | 0.13x | ₩931.19 Million | ₩260.86 Million | ₩7.06 Billion | ▼ -25.5% |
| 2016 | 0.18x | ₩1.25 Billion | ₩861.36 Million | ₩7.08 Billion | ▲ +479.7% |
| 2015 | -0.05x | ₩-611.90 Million | ₩-751.51 Million | ₩13.12 Billion | — |